The present study was conducted to determine the effect of salinomycin at a concentration 60 and 120 ppm alone and with vitamin E or selenium on haematological and biochemical parameters and histopathological changes of the treated chicken. Salinomycin (120 ppm) induced decrease in body weight, feed consumption and feed conversion efficiency. In addition, when salinomycin (120 ppm) given with vitamin E, the body performance improved significantly, but when sodium selenite used, body performance significantly decreased. Salinomycin at concentration 120 ppm induced decrease in blood parameters (RBCs count, TLC count, Hb content and PCV %). Concurrent use of vitamin E with salinomycin leads to improvement of these parameters. Salinomycin at 120 ppm induced significant increase in enzymes activities (ALT and AST). The uses of vitamin E with slinomycin (120 ppm) caused significant decrease in these activities. In contrast to selenium, which reduce the activity of AST enzyme only. Salinomycin at 120 ppm decreased the total protein concentration and increased the level of creatinine and uric acid. Concurrent administrations of vitamin E or selenium with salinomycin have no effect on these parameters. At 120 ppm salinomycin, selenium increased the creatinine concentration in blood serum. The drug at 60 or 120 ppm induced various pathological changes in certain tissues (liver, heart, kidney and skeletal muscle) ranged from degeneration to necrosis of these tissues. Concurrent administration of salinomycin with vitamin E or selenium revealed that vitamin E decreased the pathological changes of studied tissues.

The dynamics of some serum mineral concentrations during the first weeks of life of native and crossbred newborn calves in Assiut governorate were investigated. Blood samples of 25 Balady and 25 crossbred (Friesian x native) male calves were investigated. Blood was drawn from calves at 1, 7, 14 and 21 days after parturition. Serum levels of calcium (Ca), phosphorous (P), magnesium (Mg), sodium (Na), chloride (Cl), potassium (K), iron (Fe), Copper (Cu) and zinc (Zn) were monitored. Levels of Ca, P, Fe, Cu and Zn increased (P < 0.05) in relation to age of Balady and crossbred calves when compared by the day 1 of age. In contrast, decreased in concentrations of Na and Cl (P < 0.05) in relation to age of Balady and crossbred calves when compared by the day 1 of age were detected whereas Mg and K values remained unchanged. Native calves had higher (P < 0.05) Ca, P and Fe in the 7th day than crossbred calves whereas Na and Cl were higher (P < 0.05) in native calves than crossbred calves at the first day after birth. Results from this study suggested that breed and age may play an important role in mineral homeostasis during the first weeks of life in the newly borne bovine calves.

Drugs, hormones and pesticides are chemical compounds used for alleviation of various diseases in animals. There are many classes of drugs which have been used and in the case of natural steroid hormones these have been used to increase mass gain by stimulating protein anabolism. Pesticides have been used for many years in the control of ectoparasites which transmit important human and livestock diseases. The purpose of the present article is to review procedures for management of veterinary products to facilitate national and international trade.

Contagious bovine pleuropneumonia (CBPP) or lung sickness, is an insidious pneumonic disease of cattle caused by Mycoplasma mycoides subspecies mycoides small colony variant (MmmSC) and it is one of the major diseases affecting cattle in Africa. With the imminent eradication of rinderpest from Africa (Somali ecosystem) CBPP has become the disease of prime concern in terms of epizootics that affect cattle on the continent. The control and/or eradication of the disease have suffered from unsustained control actions due to lack of operational funds to support such actions and deterioration in the quality of veterinary services in many countries affected by the disease. Stamping out procedures which were adopted by Botswana to control the disease (1995-1997) cannot be carried out by many countries currently affected by CBPP due to the high financial cost, the widespread nature of disease, animal welfare considerations and the potential loss of a valuable genetic resource base. The current scenario of CBPP disease epidemiology in sub-Saharan Africa requires that proactive measures are taken to safeguard countries in southern Africa which are currently free from CBPP from being contaminated by the disease thus affecting the beef industry and people's livelihoods ; and to progressively control the disease in endemic zones of Western and Central Africa.

Finding appropriate ways of dealing with the problem of tsetse and trypanosomosis will be an important component of efforts to alleviate poverty in Africa. This article reviews the history of economic analyses of the problem, starting with the use of cost to guide choice of technique for tsetse control in the 1950s, followed by work in the 1970s and 1980s linking these to the impact of the disease on livestock productivity, and in the 1990s to its wider impact. In the current situation, with limited resources and a range of techniques for controlling or eliminating tsetse, the cost implications of choosing one technique or another are important and a recent study reviewed these costs. A novel approach to assessing the potential benefits from removing trypanosomosis by creating 'money maps' showed that high losses from animal trypanosomosis currently occur in areas with high cattle population densities on the margins of the tsetse distribution and where animal traction is an important component of farming systems. Given the importance of the decisions to be made in the next decade, when prioritising and choosing techniques for dealing with tsetse and trypanosomosis, more work needs to be done underpinning such mapping exercises and estimating the true cost and likely impact of planned interventions.

Tsetse-fly and the disease it transmits, trypanosomosis, remain an enormous disease challenge in the 37 countries of sub-Saharan Africa where the impact continues to be manifest in disease burden, increased level of poverty and decreased agricultural productivity. The impact also extends over an estimated 10 million km² (a third of the African continent) of land area, a third of which contains some well-watered part of the continent, thus denying humans and livestock of potentially rich arable and pastureland. The disease is a threat to an estimated 50 million people and 48 million cattle with estimated annual losses in cattle production alone of 1-1.2 billion US$. These losses are due to stock mortality and depressed productivity, which may be of meat, milk, reproduction or traction. Beyond its direct effects on humans and livestock is its impact on African agriculture and the livelihood of the rural population in the affected countries: the fly and the disease influence where people decide to live, how they manage their livestock, and the intensity and the mix of crop agriculture. The combined effects result in changes in land use and environment which may, in turn, affect human welfare and increase the vulnerability of agricultural activity. Trypanosomosis is, therefore, both a public health and an agricultural development constraint. The challenges that the elimination or control of tsetse fly and trypanosomosis pose as well as the opportunities to develop appropriate intervention technologies are discussed in this presentation.

The use of new, highly sensitive diagnostic methods has revealed persistent infections to be a common feature of different tick-borne diseases, such as babesiosis, anaplasmosis and heartwater. Antigenic variation can contribute to disease persistence through the continual elaboration of new surface structures, and we know in several instances how this is achieved. Known or suspected mechanisms of persistence in babesial parasites include cytoadhesion and rapid variation of the adhesive ligand in Babesia bovis and genetic diversity in several merozoite stage proteins of different Babesia spp. In Anaplasma, extensive variation in the pfam01617 gene family accompanies cycling of organism levels in chronic infection. One result from the pioneering research at Onderstepoort is the definition of a related polymorphic gene family that is likely involved in immunity against heartwater disease. We are beginning to understand the sizes of the antigenic repertoires and full definition is close, with the possibility of applying simultaneous high-throughput sequencing to the order of 1 000 small genomes. We also, for the first time, can consider modifying these genomes and looking at effects on persistence and virulence. However, important biological questions remain unanswered; for example, why we are seeing a new emerging Anaplasma infection of humans and is infection of endothelial cells by Anaplasma significant to persistence in vivo.

Babesiosis is a tick-borne disease affecting humans and many domestic and wild animals. Domestic animals showing appreciable morbidity and mortality include dogs, cats, cattle and horses. Both canine and feline babesiosis are diseases characterised by haemolytic anaemia, icterus and haemoglobinuria. Canine babesiosis can range from chronic or subclinical to peracute and fatal, depending on the virulence of the species and the susceptibility of the host. This paper deals with canine babesiosis with specific reference to pathogenesis, clinical findings, complications, diagnosis and treatment, as well as newly identified prognostic factors in Babesia rossi babesiosis.

Sir Arnold Theiler's research in 1908/09 led to the discovery of the first rickettsial pathogen, Anaplasma marginale, and set the stage for his development and implementation of an effective live vaccine based on a less virulent strain, A. marginale ss. centrale. His 1910 report, describing A. marginale, is among the classic monographs in infectious disease research, presenting not only observations in exacting detail but also highlighting the deductive reasoning leading to association of a new pathogen with a specific disease. With a centennial perspective and both conceptual frameworks and molecular tools unimaginable in Theiler's time, the significance of several observations in the original report- cyclic bacteremia, strain superinfection, and taxonomic position-is now clear and highlight the broad applicability of key principles of pathogen biology.

Heartwater is an economically serious tick-borne disease of ruminants caused by the intracellular bacterium Ehrlichia ruminantium. The disease has traditionally been controlled by four different approaches: controlling the tick vector by dipping, establishing endemic stability, performing immunisation by infection and treatment, and preventing the disease by regular administration of prophylactic antibiotics. The first three of these methods are subject to failure for various epidemiological reasons, and serious disease outbreaks can occur. Prophylaxis is effective, but very expensive, and the logistics are daunting when large herds of animals are involved. The development of a safe, cheap and effective vaccine is the only likely way in which heartwater can be economically controlled, and over the past 15 years three new types of experimental vaccine have been developed: inactivated, attenuated, and recombinant vaccines. These new vaccines have shown varying degrees of promise, but none is as yet sufficiently successful to be marketable. We describe the experimental products, and the various technical and biological difficulties which are being encountered, and report on ways in which new technologies are being used to improve vaccine effectiveness.